These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16415089)

  • 1. Clozapine modulates aromatic L-amino acid decarboxylase activity in mouse striatum.
    Neff NH; Wemlinger TA; Duchemin AM; Hadjiconstantinou M
    J Pharmacol Exp Ther; 2006 May; 317(2):480-7. PubMed ID: 16415089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of aromatic L-amino acid decarboxylase mRNA in mouse brain by in situ hybridization histology.
    Eaton MJ; Gudehithlu KP; Quach T; Silvia CP; Hadjiconstantinou M; Neff NH
    J Comp Neurol; 1993 Nov; 337(4):640-54. PubMed ID: 7904615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCH 23390 enhances exogenous L-DOPA decarboxylation in nigrostriatal neurons.
    Neff NH; Wemlinger TA; Hadjiconstantinou M
    J Neural Transm (Vienna); 2000; 107(4):429-43. PubMed ID: 11215754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-Dihydroxyphenylalanine modulates the steady-state expression of mouse striatal tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine and its metabolites in an MPTP mouse model of Parkinson's disease.
    King JM; Muthian G; Mackey V; Smith M; Charlton C
    Life Sci; 2011 Oct; 89(17-18):638-43. PubMed ID: 21871902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine hydroxylase, aromatic L-amino acid decarboxylase and dopamine metabolism after chronic treatment with dopaminergic drugs.
    Cho S; Duchemin AM; Neff NH; Hadjiconstantinou M
    Brain Res; 1999 Jun; 830(2):237-45. PubMed ID: 10366680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
    Biggs CS; Fisher A; Starr MS
    Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
    J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to mouse.
    Przybyłkowski A; Kurkowska-Jastrzebska I; Joniec I; Ciesielska A; Członkowska A; Członkowski A
    Brain Res; 2004 Sep; 1019(1-2):144-51. PubMed ID: 15306248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation by D2 dopamine receptors of in vivo dopamine synthesis in striata of rats and mice with experimental parkinsonism.
    Richard MG; Bennett JP
    Exp Neurol; 1994 Sep; 129(1):57-63. PubMed ID: 7925842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors.
    Hadjiconstantinou M; Wemlinger TA; Sylvia CP; Hubble JP; Neff NH
    J Neurochem; 1993 Jun; 60(6):2175-80. PubMed ID: 8492125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatic L-amino acid decarboxylase turnover in vivo in rhesus macaque striatum: a microPET study.
    DeJesus OT; Flores LG; Murali D; Converse AK; Bartlett RM; Barnhart TE; Oakes TR; Nickles RJ
    Brain Res; 2005 Aug; 1054(1):55-60. PubMed ID: 16055094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
    Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs.
    Cho S; Neff NH; Hadjiconstantinou M
    Eur J Pharmacol; 1997 Apr; 323(2-3):149-57. PubMed ID: 9128833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nigrostriatal reduction of aromatic L-amino acid decarboxylase activity in MPTP-treated squirrel monkeys: in vivo and in vitro investigations.
    Yee RE; Huang SC; Stout DB; Irwin I; Shoghi-Jadid K; Togaski DM; DeLanney LE; Langston JW; Satyamurthy N; Farahani KF; Phelps ME; Barrio JR
    J Neurochem; 2000 Mar; 74(3):1147-57. PubMed ID: 10693947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing aromatic L-amino acid decarboxylase activity: implications for L-DOPA treatment in Parkinson's disease.
    Hadjiconstantinou M; Neff NH
    CNS Neurosci Ther; 2008; 14(4):340-51. PubMed ID: 19040557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism.
    Kozina EA; Kim AR; Kurina AY; Ugrumov MV
    Neurobiol Dis; 2017 Feb; 98():108-121. PubMed ID: 27940203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive assessment of aromatic L-amino acid decarboxylase activity in aging rhesus monkey brain in vivo.
    Dejesus OT; Endres CJ; Shelton SE; Nickles RJ; Holden JE
    Synapse; 2001 Jan; 39(1):58-63. PubMed ID: 11071710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of guanylyl cyclase expression and activity in striatum of MPTP-induced parkinsonism in mice.
    Chalimoniuk M; Langfort J; Lukacova N; Marsala J
    Biochem Biophys Res Commun; 2004 Nov; 324(1):118-26. PubMed ID: 15464991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced MPTP neurotoxicity after treatment with isoflurophate or cholinergic agonists.
    Hadjiconstantinou M; Hubble JP; Wemlinger TA; Neff NH
    J Pharmacol Exp Ther; 1994 Aug; 270(2):639-44. PubMed ID: 7915317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine hydroxylase mRNA and protein are down-regulated by chronic clozapine in both the mesocorticolimbic and the nigrostriatal systems.
    Tejedor-Real P; Faucon Biguet N; Dumas S; Mallet J
    J Neurosci Res; 2003 Apr; 72(1):105-15. PubMed ID: 12645084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.